← Eichor
Condition: Sarcoidosis Pulmonary Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Sarcoidosis Pulmonary

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
Phase 4 · 21 location(s) · Hospices Civils de Lyon · NCT05841758Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens
Phase N/A · 1 location(s) · Johns Hopkins University · NCT05171478Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease
NA · 1 location(s) · Université Catholique de Louvain · NCT07384897RCT of Nintedanib in Fibrotic Sarcoidosis
Phase 4 · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT06479603Comparative Diagnostic Yield of Endobronchial Cryo Biopsy vs Forceps Biopsy in Patients With Suspected Sarcoidosis
NA · 1 location(s) · Sanjay Gandhi Postgraduate Institute of Medical Sciences · NCT06853834Sarcoidosis and Immune Cells in Lung, Lymph Nodes and Blood
NA · 1 location(s) · Region Stockholm · NCT05751447Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases
Phase 2 · 1 location(s) · Odense University Hospital · NCT04924270Role of Genetic Factors in the Development of Lung Disease
Phase N/A · 2 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00001532Interstitial Lung Disease Research Unit Biobank
Phase N/A · 1 location(s) · University of Kansas Medical Center · NCT05392881A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Phase N/A · 1 location(s) · University of Chicago · NCT00470327AYLo - AutoimmunitY and Loss of y
Phase N/A · 1 location(s) · University of Bonn · NCT06696027Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
Phase 2 · 28 location(s) · Molecure S.A. · NCT06205121Mediastinal EBUS Cryobiopsy Study In Sweden
Phase N/A · 2 location(s) · Region Skane · NCT06347939A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Phase 1/Phase 2 · 34 location(s) · Xentria, Inc. · NCT05890729Comparison of the Effects of Yoga and Conventional Physiotherapy Programs in Sarcoidosis
NA · 1 location(s) · Saglik Bilimleri Universitesi · NCT06848608Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) Epidemiology Non-interventional Study (NIS)
Phase N/A · 1 location(s) · Boehringer Ingelheim · NCT05819385Risk Indicators of Sarcoidosis Evolution-Unified Protocol
Phase N/A · 2 location(s) · University of California, San Francisco · NCT05567133Institutional Registry of Rare Diseases
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06573723Feasibility of Semaglutide in Advanced Lung Disease
Phase 1/Phase 2 · 1 location(s) · University of Pennsylvania · NCT05746039
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.